ACHV
Achieve Life Sciences, Inc.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Best Diagnostics Stocks 2026 →
Achieve Life Sciences (ACHV) Stock: Buy, Sell, or Hold?
$6.78
+0.06 (+0.89%)
▲
5d:
+2.57%
30d:
-8.5%
90d:
+0.15%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (83%)
Quality Score
56/100
Position
SLIGHTLY LOW
30-Day Fair Range
$6.55 – $7.17
Position: SLIGHTLY LOW
Forward P/E & Valuation
-10.4x
Next 12M consensus est.
Wall Street Target
$14.15
+108.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.25 / $7.29
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ACHV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $6.78, which is considered slightly low relative to its 30-day fair value range of $6.55 to $7.17.
Technical Outlook: Technically, ACHV is in a downtrend. Immediate support is located at $6.25, while resistance sits at $7.29.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.15 (+108.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACHV is in a downtrend. Immediate support is located at $6.25, while resistance sits at $7.29.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.15 (+108.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.55 -
$7.17
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$6.55 -
$7.17
Current vs Trading Range
SLIGHTLY LOW
Support Level
$6.25
Resistance Level
$7.29
Current Trend
Downtrend
Technical data as of
Nov 9, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 108.8% below Wall St target ($14.15)
- NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-10.39
Wall Street Target
$14.15
(+108.8%)
Share ACHV Analysis
Share this live ACHV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACHV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 9, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $ACHV with no recent news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:04 AM ET
Data refreshes hourly during market hours. Next update: 9:04 AM
Data refreshes hourly during market hours. Next update: 9:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACHV Research Pages
